Piot G, Droz J P, Theodore C, Ghosn M, Rouëssé J, Amiel J L
Service de Médecine, Institut Gustave-Roussy, Villejuif, France.
Oncology. 1988;45(5):371-2. doi: 10.1159/000226643.
Sixteen patients with adult metastatic renal cell carcinoma were treated with elliptinium acetate, 80 mg/m2.day, for 3 consecutive days every 3 weeks. Among the 14 patients evaluable, no objective effects were observed. The toxicity was mild and no patients experienced intravascular hemolysis.
16例成人转移性肾细胞癌患者接受醋酸椭圆玫瑰树碱治疗,剂量为80mg/m²·天,每3周连续给药3天。在14例可评估的患者中,未观察到客观疗效。毒性较轻,无患者发生血管内溶血。